Division of Genomic Diagnostics CANCER GENOMIC TEST REQUISITION Page 1 of 6

Similar documents
CentoCancer STRIVE FOR THE MOST COMPLETE INFORMATION

patient guide CancerNext-Expanded genetic testing for hereditary cancer Because knowing your risk can mean early detection and prevention

TGL clinical User Guide

The Next Generation of Hereditary Cancer Testing

The Center for PERSONALIZED DIAGNOSTICS

Your single-source laboratory solution. FISH Probe Library

Genetic Risk Assessment for Cancer

OncoGeneDx Test Requisition Form

Are you at risk of Hereditary Cancer? Your Guide to the Answers

Germline Multigene Panel Testing in Oncology: Genetic Counseling Perspective

WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.

MOLECULAR SERVICES. mlabs.umich.edu

OncoGeneDx Test Requisition Form

Clinical Cancer Genetics

Learn your genetic risk for the most common hereditary cancers.

A guide to genetic testing for hereditary cancers

The benefit of. knowing. Genetic testing for hereditary cancer. A patient support guide

WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.

NeoTYPE Cancer Profiles

DNA Genetic Cancer Risk Test. Test Report

Out-Patient Billing CPT Codes

patient guide CancerNext genetic testing for hereditary cancer Because knowing your risk can mean early detection and prevention

Genetic testing for hereditary cancer

NeoTYPE Cancer Profiles

patient guide RenalNext genetic testing for hereditary kidney cancer Because knowing your risk can mean early detection and prevention

Hereditary Cancer. Genetic Testing Services. The GeneDx Experience

GYNplus: A Genetic Test for Hereditary Ovarian and/or Uterine Cancer

Molecular. Oncology & Pathology. Diagnostic, Prognostic, Therapeutic, and Predisposition Tests in Precision Medicine. Liquid Biopsy.

Genetic Risk Assessment for Cancer

Cancer Survivorship Symposium Cancer and Heredity January 16, Jeanne P. Homer, MS Licensed Certified Genetic Counselor

EXT ADDRESS CITY LAST NAME ID NUMBER PT. ADDRESS CITY INSURANCE PROVIDER. 0 Other. 0 IGH/B-cell cionaliry (PCR)

MEDICAL POLICY Genetic Testing for Breast and Ovarian Cancers

Expert Interview: Inherited Susceptibility to Cancer with Dr. Nicoleta Voian

TEST MENU TEST CPT CODES TAT. Chromosome Analysis Bone Marrow x 2, 88264, x 3, Days

patient guide BrainTumorNext genetic testing for hereditary brain tumors Because knowing your risk can mean early detection and prevention

GYNplus. genetic testing for hereditary ovarian and/or uterine cancer

A CANCER GENETICIST S (2 ND ) BEST FRIEND IS THEIR PATHOLOGIST. Dr Alan Donaldson Consultant in Clinical Genetics St Michaels Hospital Bristol

Corporate Medical Policy

OvaNext. patient guide. genetic testing for hereditary breast, ovarian, and uterine cancer

Genomic Medicine: What every pathologist needs to know

Be Ready Pack Learn more about how Myriad myrisk is revolutionizing hereditary cancer testing.

August 17, Dear Valued Client:

FIRST NAME MI LAST NAME BIRTH DATE (MM/DD/YYYY) GENDER. Name of person previously tested and relationship:

Medical Policy Update

IntelliGENSM. Integrated Oncology is making next generation sequencing faster and more accessible to the oncology community.

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

A Patient s Guide to Hereditary Cancer. Is Hereditary Cancer Testing Right for You?

Select analysis on the next pages. Sample request and sending address see last page. Institut für Pathologie und Molekularpathologie

Genetic Cancer Susceptibility Panels Using Next Generation Sequencing

PROVIDER POLICIES & PROCEDURES

Test Requisition Form

Versus. Cancer genomics Competitive Analysis

6/8/17. Genetics 101. Professor, College of Medicine. President & Chief Medical Officer. Hereditary Breast and Ovarian Cancer 2017

Clinical Grade Genomic Profiling: The Time Has Come

Comprehensive Test Menu December 2018

Germline Testing for Hereditary Cancer with Multigene Panel

Information for You and Your Family

Assessment and Management of Genetic Predisposition to Breast Cancer. Dr Munaza Ahmed Consultant Clinical Geneticist 2/7/18

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Prices listed correspond to institutional rates only; please contact the lab for insurance rates.

Date of Birth Gender Ethnicity/Family History Male Female Unknown. (Institutional Billing only. We DO NOT bill patients directly.)

Why Test for Hereditary Cancer in Preventive Care?

MEDICAL GENOMICS LABORATORY. Peripheral Nerve Sheath Tumor Panel by Next-Gen Sequencing (PNT-NG)

Genetic Cancer Susceptibility Panels Using Next Generation Sequencing

Jennifer Hauenstein Oncology Cytogenetics Emory University Hospital Atlanta, GA

Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS

SureSelect Cancer All-In-One Custom and Catalog NGS Assays

patient guide PancNext genetic testing for hereditary pancreatic c a ncer Because knowing your risk can mean early detection and prevention

Hereditary Cancer Products

OncoGeneDx Test Requisition Form (River City)

Prices listed correspond to institutional rates only; please contact the lab for insurance rates.

Genetic Cancer Susceptibility Panels Using Next Generation Sequencing. Policy Specific Section: September 27, 2013 January 30, 2015

YES. If yes, indicate what types of tumors/polyps and age of onset:

patient guide BreastNext genetic testing for hereditary breast cancer Because knowing your risk can mean early detection and prevention

Populations Interventions Comparators Outcomes Individuals: With a personal and/or family history suggesting an inherited cancer syndrome

Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS

Targeted Agent and Profiling Utilization Registry (TAPUR ) Study. February 2018

Enabling Personalized

Original Policy Date

molecular oncology services

Comprehensive Test Menu August 2018

The Role of genetic Testing for Inherited Prostate Cancer Risk

Russell-Silver syndrome (RSS)

Informed Consent Columbia Whole Genome or Whole Exome Sequencing

patient guide ProstateNext genetic testing for hereditary prostate cancer Because knowing your risk can mean early detection and prevention

Accession: Additional testing information is available at

Genetic Testing for Hereditary Cancer Susceptibility Syndromes

UNIVERSITY OF PENNSYLVANIA GENETIC DIAGNOSTIC LABORATORY

Myriad Financial Assistance Program (MFAP)

Prices listed correspond to institutional rates only; please contact the lab for insurance rates.

Genetic testing and pancreatic disease

Personalised cancer care Information for Medical Specialists. A new way to unlock treatment options for your patients

Prior Authorization. Additional Information:

Accel-Amplicon Panels

MSI positive MSI negative

Genetic Testing for BRCA1 and BRCA2 Genes

Transcription:

Page 1 of 6 SHIP TO: Children s Hospital of Philadelphia, Genomic Diagnostic Laboratory, 3615 Civic Center Blvd., Abramson Research Center, 714, Philadelphia, PA 19104-4302 - Phone: (215) 590-4452 Patient Name (Last, First, Middle): PATIENT INFORMATION SAMPLE INFORMATION What is the surgical pathology identifi cation number?: Collection Date (Month/Day/Year): Ordering Facility MRN: Did the patient previously have a bone marrow transplant? Yes No Does the sample contain tumor/blasts? Yes No If yes, please include the pathology report and indicate the percentage of Fetus of above patient (Check if prenatal sample) Sex: Male Female Unknown Other: tumor or blast nuclei in the sample: <10% (unacceptable) 10-29% 30-50% >50% Sample Type (please see sample requirements on page 4): Bone Marrow Aspirate Date of Birth (Month/Day/Year): Purple Top Tube (EDTA) Street Address: Green Top Tube (Sodium Heparin) Frozen Tissue OCT Snap or Flash Frozen City/State: Zip/Country: Formalin Fixed Paraffi n Embedded Tumor Block Scrolls Request return of tumor block Yes No Fresh Tissue in RPMI media Phone Number: Blood Purple Top Tube (EDTA) Race/Ethnicity: Amish Asian Black/African-American Green Top Tube (Sodium Heparin) Cerebral Spinal Fluid *Bone Marrow Biopsy Caucasian East Indian French Canadian *Cultured CVS Cells *Cultured Amniotic Fluid Hispanic Jewish-Ashkenazi Jewish-Sephardic *Cheek Brush *Saliva *Please contact the lab if sending this sample type Mediterranean Native American cdna: Specify Tissue of Origin: DNA: Specify Tissue of Origin: Other: Other (Specify): ORDERING PROVIDER ORDERING LABORATORY OTHER ORDERING PROVIDER / GENETIC COUNSELOR Name (Last, First, Degree) Phone Fax Name (Last, First, Degree) Phone Fax Name (Last, First, Degree) Phone Fax Institution Institution Email Street Address Street Address City State City State Zip Country Zip Country Email Email For Lab Use Only Type of billing: Institutional CHOP Self-pay Institution called Comments: Received by: Received Date: Received Time: Sample: Phone: (215) 590-4452; Fax: (215) 590-3514; Website: http://www.chop.edu/centers-programs/division-genomic-diagnostics *Testing will not be initiated until all necessary samples and clinical information are submitted to the laboratory.

Page 2 of 6 INDICATION FOR TESTING Reason for testing (please include pertinent history and fi ndings, including pathology report): Family History (Attach Pedigree if available): Previous Relevant Genetic Testing: Previous Relevant Genetic Testing Performed (Attach a copy): Yes No If yes, sample type: Chorionic Villus Amniocentesis Blood Bone Marrow Tissue Results: Known Genetic Abnormality/Familial Testing: Is the current patient who is being tested similarly affected to proband (person originally tested)? Yes No If yes, please describe: *Attach proband (originally tested family member) report if available. Gene/Transcript/Region: Alteration (c., p., and/or g.): Proband (originally tested family member) Name (Last, First): Proband (originally tested family member) Date of Birth (Month/Day/Year): Current patient s relationship to the proband (originally tested family member): SEQUENTIAL TESTING If sequential testing is indicated for this patient, list the order of testing here, or number the tests in the menu: Initial Test: Refl ex to: Refl ex to: if Positive/ Negative then: if Positive/ Negative then: if Positive/ Negative then: Refl ex to: *Please contact the laboratory to request expedited testing.

Page 3 of 6 TEST MENU Please add instructions for reflex/sequential testing on previous page. For a current list of genes please visit http://www.chop.edu/centers-programs/division-genomic-diagnostics. Somatic Cancer Testing Panel Testing: Comprehensive Solid Tumor NGS Panel (Solid + Fusion) Solid Tumor NGS Panel Comprehensive Hematological NGS Cancer Panel (Heme + Fusion) Heme NGS Panel Cancer Gene-Fusion Panel Chromosomal Microarray Analysis (not suitable for Paraffin Embedded Tumor): Cancer SNP Array Chromosome Analysis: Karyotype Fluorescence In Situ Hybridization (FISH): ABL1/BCR DF (9q34/22q11.2) CBFB (Inversion 16q22.1) CDKN2A (9p21) CSF1R (5q33q34) Deletion 7 DXZ1/DYZ3 ETV6 (12p13) ETV6/RUNX1 (12p13/21q22) EWSR1 (22q12) EVI1 (Inversion 3) FOXO1 (13q14) IGH (14q32) BAP IGH/MYC (8q24/14q32) KMT2A(MLL) (11q23) MEGF6, TP73/ANGPTL, ABL2 (1p36/1q25) MYC (8q24) MYCN (2p24) NUP98 (11p15) PAX3 (2q35) PAX7 (1p36) PBX1/TCF3 (1q23/19p13.3) PDGFRA (4q12) PDGFRB (5q33.2) PML/RARA (15q22/17q21.1) PTCH1 (9q22.3) PTEN (10cen/10q23) RUNX1 (21q22) RUNX1T1/RUNX1 DF (8q21.3/21q22) SS18 (18q11.2) TCR (alpha/delta) (14q11.2) 4cen/10cen 10/19q Codeletion (1p36/1q25; 19p13/19q13) Other (specify) Cancer Related BRAF Testing: BRAF Sequence Analysis of Exon 15 IDH1 Testing: IDH1 Sequence Analysis of Exon 4 Somatic Cancer Testing (cont'd) JAK1/JAK2 Testing: JAK1/JAK2 Lymphoid Panel JAK1 Sequence Analysis of Exons 13 and 14 and JAK2 Sequence Analysis of Exons 20 and 21 JAK2 Sequence Analysis of Exon 16 (with refl ex testing to JAK1/JAK2 Lymphoid Panel) JAK2 Sequence Analysis of Exon 14 (with refl ex testing to JAK2 Sequence Analysis of Exon 12) JAK2 Sequence Analysis of Exon 12 Neuroblastoma: ALK Sequence Analysis Refl ex to Germline ALK Targeted Sequence Analysis if positive NPM1 Testing: NPM1 Sequence Analysis of Exon 12 SMARCB1 Testing: SMARCB1 Deletion/Duplication Analysis Refl ex to Germline SMARCB1 Deletion/Duplication SMARCB1 Sequence Analysis (typically ordered if deletion/ duplication analysis is not fully diagnostic) Refl ex to Germline Targeted SMARCB1 Sequence Analysis if positive Germline Cancer Testing Panel Testing: Comprehensive Hereditary Cancer Panel Hereditary Brain Tumor Panel: ALK, APC, ATM, MEN1, MLH1, MSH2, MSH6, PMS2, NBN, NF1 NF2, PALB2, PHOX2B, PTCH1, SMARCB1, SUFU, TP53, and VHL Hereditary Breast, Ovarian, and Endometrial Cancer Panel Hereditary High-Risk Breast Cancer Panel: BRCA1, BRCA2, CDH1, PALB2, PTEN, STK11, and TP53 Hereditary Colorectal and Gastrointestinal Cancer Panel: APC, BMPR1A, EPCAM, MLH1, MSH2, MSH6, PMS2, MUTYH, PTEN, SMAD4, STK11, and TP53 Hereditary High-Risk Colorectal Cancer Panel Hereditary Neuroendocrine Cancer Panel Hereditary Kidney Cancer Panel Hereditary Melanoma Panel: BAP1, BRCA1, BRCA2, CDK4, CDKNA2, PTEN, RB1, TERT, TP53, and WRN Hereditary Pancreatic Cancer Panel APC, ATM, BMPR1A, BRCA1, BRCA2, CDK4, CDKNA2, EPCAM, MLH1, MSH2, MSH6, PMS2, PALB2, PRSS1, SMAD4, STK11, TP53, and VHL Hereditary Paraganglioma/Pheochromocytoma Panel FH, MAX, MEN1, NF1, RET, SDHA, SDHAF2, SDHB, SDHC, SDHD, TMEM127, and VHL Hereditary Prostate Cancer Panel BRCA1, BRCA2, CHEK2, NBN, and TP53 Refl ex to Comprehensive Hereditary Cancer Panel Comprehensive BMF/MDS/Leukemia Predisposition Panel Bone Marrow Failure Panel

Page 4 of 6 Germline Cancer Testing (cont'd) Panel Testing (cont'd): Fanconi Anemia/ Rare Chromosomal Breakage Disorders Panel Hereditary MDS/Leukemia Predisposition Panel Inherited Neutropenia Panel Inherited Red Blood Cell Disorder Panel Inherited Thrombocytopenia Panel Telomere Disorder Panel ACD, CTC1, DKC1, NHP2, NOP10, PARN, RTEL1, TERC, TERT, TINF2, and WRAP53 Comprehensive BMF/MDS/Leukemia Predisposition Panel Reflex Birt-Hogg-Dubé Syndrome: FLCN Sequence Analysis FLCN Deletion/Duplication Analysis Brooke Spiegler Syndrome/Familial Cylindromatosus: CYLD Sequence Analysis Hereditary Leiomyomatosis and Renal Cell Carcinoma: FH Sequence Analysis FH Deletion/Duplication Analysis Hereditary Papillary Renal Cell Carcinoma: MET Proto-Oncogene Sequence Analysis of Exons 16-19 Multiple Endocrine Neoplasia: MEN2 Ret Proto-Oncogene Full Sequence Analysis MEN2A and MEN2B Ret Proto-Oncogene Sequence Analysis of Exons 10, 11, 13-16 MEN2A Ret Proto-Oncogene Sequence Analysis of Exons 10, 11, 13-15 MEN2B Ret Proto-Oncogene Sequence Analysis of Exon 16 Neuroblastoma: ALK Sequence Analysis PHOX2B Sequence Analysis (not suitable for tumor samples) NUDT15 Testing: NUDT15 Sequencing PTEN Hamartoma Tumor Syndrome: PTEN Sequence Analysis PTEN Deletion/Duplication Analysis TPMT Testing: TPMT Sequencing SMARCB1 Testing: SMARCB1 Sequence Analysis SMARCB1 Deletion/Duplication Analysis Von Hippel Lindau: VHL Sequence Analysis VHL Deletion/Duplication Analysis Custom Gene Testing (contact lab for availability): Custom Gene Sequencing: Custom Gene Deletion/Duplication Analysis: Custom Known Mutation Testing: Other (Please Specify):

Page 5 of 6 Sample Requirements Blood The Panel Testing and Single Gene and Region Specifi c Testing menus require 3-5mL of blood in an EDTA (purple top) tube. Chromosome Analysis requires 3-5mL of blood in an EDTA (purple top) tube and 3-5mL in a Sodium Heparin (green top) tube. Bone Marrow Aspirate For testing on a bone marrow aspirate, 3-5 ml is needed in an EDTA (purple top) tube if ordering panel testing, array, and/or targeted gene testing whereas 3-5 ml is needed in an NaHep (green top) tube if ordering chromosome analysis or FISH testing. Please include a pathology report that indicates percentage blasts in the aspirate specimen. DNA Most tests require 5-10ug of DNA with a minimum concentration of 50ng/uL. Panel testing requires 8ug of DNA. Please refer to the divisional website for specifi c amounts of DNA required for each test. Cultured CVS Cells or Cultured Amniotic Fluid This sample type requires 2 nearly confl uent T-25 fl asks. Please contact the laboratory if ordering prenatal testing. Fresh or Frozen Tumor Tissue For Cancer Testing, 0.5cm 3 of tissue is needed. Please indicate percentage tumor nuclei in sample on Page 1 in the Sample Information section. Also include a pathology report. FFPE Sample The lab prefers to receive the formalin fi xed paraffi n-embedded (FFPE) tumor block. Tissue scrolls (4-6) cut at 20 microns with an accompanying H&E may also be acceptable for DNA-based testing. If sending an FFPE block, please provide the FedEx number to use for return shipment along with the return address. Shipping Instructions Samples should be shipped by overnight carrier to arrive Monday-Friday. Most samples should be sent at room temperature. Frozen tumor samples should be sent on dry ice. Shipping address Children s Hospital of Philadelphia Genomic Diagnostic Laboratory 3615 Civic Center Blvd. Abramson Research Center, 714 Philadelphia, PA 19104-4302 Phone: (215) 590-4452 Necessary Documents Each sample should be sent with a completed Test Requisition Form, including billing information, and Consent Form (if applicable). Pathology Reports Please include pathology reports including tumor percentage if sending tumor samples. Previous Family Reports Please include family member test reports if ordering known genetic abnormality/familial testing. Results from Prior Testing Please include results from prior genetic testing or other related reports (such as hemoglobin electrophoresis for thalassemia testing, pathology reports for any testing on tumors, or other testing that may provide necessary clinical information for genetic testing). Pedigree Please include a copy of the patient s family pedigree, especially if other family members are similarly affected. The pedigree should include genotype and phenotype information for all tested family members. Page 6 is billing information and will be removed from the requisition once no longer needed.

Page 6 of 6 Please note: we do not bill patient insurance directly. Billing Options (For Non-CHOP patients only) Institutional Billing Option ICD-10 Diagnosis Codes for Billing: Bill to Institution/Department: Address: Billing Contact: Phone: Fax: Email: Please provide FedEx number to use for return shipment if requested: Self Pay Option Total Cost Approved: Credit Card: Visa American Express Discover MC Name on Card: Cardholder Date of Birth: Month/Day/Year Card Number: Expiration Date: Billing Address: Month/Year CCV (security # on back): Phone: Email: Cardholder Signature Printed Name Date (Month/Day/Year) Time *Cardholders signature indicates authorization to bill Credit Card For Lab use only: